The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations
Abstract
Abstract.: This study correlated the dynamic effects of sirolimus (rapamycin; RAPA) and cyclosporine (CsA) alone versus in combination to produce renal dysfunction, myelosuppression, or hyperlipidemia, with their corresponding blood and tissue concentrations. After salt-depleted rats were treated with RAPA (0.4 to 6.4 mg/kg per d) and/or CsA (2.5 to 20.0 mg/kg per d) for 14 d, the GFR, lipid levels, bone marrow cellularity, and CsA/RAPA concentrations in whole blood versus liver or renal tissues were measured, and the median effect model was used to discern the type of drug interactions. Compared with vehicle controls (1.98 ± 0.34 ml/min), GFR values were reduced only by large doses of drug monotherapy, namely RAPA (3.2 mg/kg per d = 1.2 ± 0.02 ml/min or 6.4 mg/kg per d = 1.3 ± 0.2 ml/min; both P < 0.01) or CsA (10.0 mg/kg per d = 1.2 ± 0.1 ml/min or 20.0 mg/kg per d = 0.8 ± 0.4 ml/min; both P < 0.01). In contrast, hosts that were treated with smaller doses of CsA/RAPA combinations showed more pronounced effects in reduction of GFR values: 2.5/0.4 mg/kg per d, modestly (1.5 ± 0.5 ml/min; P < 0.01); 5.0/0.8 mg/kg per d, moderately (0.23 ± 0.01 ml/min; P < 0.001); and higher-dose groups, markedly. The exacerbation of renal dysfunction seemed to be due to a pharmacokinetic interaction of RAPA to greatly increase CsA concentrations in whole blood and, particularly, in kidney tissue. In contrast, the pharmacodynamic effects of CsA to potentiate two RAPA-mediated toxicities—myelosuppression and increased serum cholesterol/low-density lipoprotein cholesterol—occurred independently of pharmacokinetic interactions. RAPA aggravates CsA-induced renal dysfunction owing to a pharmacokinetic interaction, whereas CsA produces a pharmacodynamic effect that augments RAPA-induced myelosuppression and hyperlipidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
Self-citation
Cited by
Chou, T.-C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.10 · Cited by 5,163
Self-citationCalcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
Flechner, S. M., Kobashigawa, J., & Klintmalm, G. (2008) · Clinical Transplantation · doi:10.1111/j.1399-0012.2007.00739.x · Cited by 310
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
Olyaei, A. J., de Mattos, A. M., & Bennett, W. M. (2001) · Current Opinion in Critical Care · doi:10.1097/00075198-200112000-00003 · Cited by 291
Vitko, S., Tedesco, H., Eris, J., Pascual, J., Whelchel, J., Magee, J. C., Campbell, S., Civati, G., Bourbigot, B., Filho, G. A., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00389.x · Cited by 254
Metadata
- Authors
- PODDER, H., STEPKOWSKI, S. M., NAPOLI, K. L., CLARK, J., VERANI, R. R., CHOU, T.-C., & KAHAN, B. D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2001-05
- Volume
- 12
- Issue
- 5
- Pages
- 1059-1071
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2128257213
- Cited by
- 221
- References
- 1
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations. https://app.cochat.ai/papers/10.1681/asn.v1251059
- The paper
- PODDER, H., STEPKOWSKI, S. M., NAPOLI, K. L., CLARK, J., VERANI, R. R., CHOU, T.-C., & KAHAN, B. D. (2001). Pharmacokinetic Interactions Augment Toxicities of Sirolimus/Cyclosporine Combinations. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.v1251059
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.